Fact based stock research
Steris (NYSE:STE)


Steris stock research in summary

steris.com


Steris shares have a HOLD rating. While they are good value, they show below average growth, and are riskily financed. We recommend holding Steris shares.


Latest Obermatt Ranks


Country United Kingdom
Industry Health Care Equipment
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Large

February 1, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock






 

Research History: Steris

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
75
81
77
77
STOCK GROWTH RANKS
74
93
26
26
STOCK SAFETY RANKS
15
26
20
20
COMBINED STOCK RANKS
79
80
35
35

Last update of Combined Rank: 1-Feb-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Steris in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 1-Feb-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Steris; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
84
86
29
29
PROFIT GROWTH
33
65
24
24
STOCK RETURNS
55
60
52
52
CONSOLIDATED RANK: GROWTH
74
93
26
26

Financial reporting date of Growth Rank: 30-Sep-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Steris.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
14
37
20
20
REFINANCING
35
35
LIQUIDITY
40
39
60
60
CONSOLIDATED RANK: SAFETY
15
26
20
20

Financial reporting date of Safety Rank: 30-Sep-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Steris and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Steris from February 1, 2018.